Ikarian Capital, LLC Kinnate Biopharma Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.43 - $13.0 $14,785 - $25,870	-1,990 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.5 - $25.48 $32,835 - $50,705	1,990 New	1,990 $35,000
Q2 2021 Aug 16, 2021	SELL	$22.19 - $31.55 $44,380 - $63,100	-2,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$36.35 - $45.25 $72,700 - $90,500	2,000 New	2,000 $79,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.